Estimated Familial Amyotrophic Lateral Sclerosis Proportion: A Literature Review and Meta-analysis
Neurology Genetics
by Barberio, J., Lally, C., Kupelian, V., Hardiman, O., Flanders, W. D.
3M ago
Background and Objectives Amyotrophic lateral sclerosis (ALS) is a rare neurodegenerative disorder. Familial (fALS) cases are usually reported to constitute 5%–10% of all ALS cases; however, no recent literature review or meta-analysis of this proportion (referred to throughout as "proportion fALS") has been conducted. Our objective was to estimate the proportion fALS by geographic region and to assess the effect of study characteristics on the estimates. Methods A comprehensive literature review was performed to identify all original studies reporting the number of fALS cases in an ALS cohort ..read more
Visit website
Ataxia Syndrome With Hearing Loss and Nephronophthisis Associated With a Novel Homozygous Variant in XPNPEP3
Neurology Genetics
by Ben-Shabat, I., Kvarnung, M., Sperker, W., Bruhn, H., Wredenberg, A., Wibom, R., Nennesmo, I., Engvall, M., Paucar, M.
3M ago
Objectives Biallelic variants in XPNPEP3 are associated with a rare mitochondrial syndrome characterized by nephronophthisis leading to kidney failure, essential tremor, hearing loss, seizures, and intellectual disability. Only 2 publications on this condition are available. We report a man with a complex ataxia syndrome, hearing loss, and kidney failure associated with a new biallelic variant in XPNPEP3. Methods Clinical evaluation, neuroimaging studies, a kidney biopsy, and whole genome sequencing (WGS) were applied. Since the phenotype was compatible with a mitochondrial disease, a muscle b ..read more
Visit website
Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy in Patients Clinically Suspected of FSHD Using Optical Genome Mapping
Neurology Genetics
by Guruju, N. M., Jump, V., Lemmers, R., Van Der Maarel, S., Liu, R., Nallamilli, B. R., Shenoy, S., Chaubey, A., Koppikar, P., Rose, R., Khadilkar, S., Hegde, M.
3M ago
Background and Objectives Facioscapulohumeral muscular dystrophy (FSHD) represents the third most common muscular dystrophy in the general population and is characterized by progressive and often asymmetric muscle weakness of the face, upper extremities, arms, lower leg, and hip girdle. In FSHD type 1, contraction of the number of D4Z4 repeats to 1–10 on the chromosome 4–permissive allele (4qA) results in abnormal epigenetic derepression of the DUX4 gene in skeletal muscle. In FSHD type 2, epigenetic derepression of the DUX4 gene on the permissive allele (4qA) with normal-sized D4Z4 repeats (m ..read more
Visit website
Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
Neurology Genetics
by Kang, P. B., Jorand-Fletcher, M., Zhang, W., McDermott, S. W., Berry, R., Chambers, C., Wong, K. N., Mohamed, Y., Thomas, S., Venkatesh, Y. S., Westfield, C., Whitehead, N., Johnson, N. E., for the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
3M ago
Background and Objectives To report the genetic etiologies of Emery-Dreifuss muscular dystrophy (EDMD), limb-girdle muscular dystrophy (LGMD), congenital muscular dystrophy (CMD), and distal muscular dystrophy (DD) in 6 geographically defined areas of the United States. Methods This was a cross-sectional, population-based study in which we studied the genes and variants associated with muscular dystrophy in individuals who were diagnosed with and received care for EDMD, LGMD, CMD, and DD from January 1, 2008, through December 31, 2016, in the 6 areas of the United States covered by the Muscula ..read more
Visit website
Adult Phenotype of SYNGAP1-DEE
Neurology Genetics
by Rong, M., Benke, T., Zulfiqar Ali, Q., Aledo-Serrano, A., Bayat, A., Rossi, A., Devinsky, O., Qaiser, F., Ali, A. S., Fasano, A., Bassett, A. S., Andrade, D. M.
3M ago
Background and Objectives SYNGAP1 variants are associated with rare developmental and epileptic encephalopathies (DEEs). Although SYNGAP1-related childhood phenotypes are well characterized, the adult phenotype remains ill-defined. We sought to investigate phenotypes and outcomes in adults with SYNGAP1 variants and epilepsy. Methods Patients 18 years or older with DEE carrying likely pathogenic and pathogenic (LP/P) SYNGAP1 variants were recruited through physicians' practices and patient organization groups. We used standardized questionnaires to evaluate current seizures, medication use, sle ..read more
Visit website
PMPCA-Related Encephalopathy: Novel Variants, Phenotype Extension, and Mitochondrial Morphology
Neurology Genetics
by Rambani, V., Kolnikova, M., Cagalinec, M., Skopkova, M., Gasperikova, D.
3M ago
Objectives The PMPCA gene encodes the α-subunit of mitochondrial processing peptidase (α-MPP), an enzyme responsible for cleavage of nuclear-encoded mitochondrial precursor proteins after their import into mitochondria. Mutations in this gene have been described in patients with nonprogressive or slow progressive cerebellar ataxia, with variable age at onset and severity. Cerebellar atrophy and striatum changes were found in severe cases. Methods The patient was diagnosed using whole exome sequencing. Skin fibroblasts were used for confirmation of α-MPP levels using western blot and mitochondr ..read more
Visit website
Expanding the Clinical Spectrum of UBTF-Related Neurodevelopmental Disorder
Neurology Genetics
by Pietra, A., Palombo, F., Giannotta, M., Maffei, M., Fiorini, C., Costa, R., Cenacchi, G., Carelli, V., Cordelli, D. M., Pini, A., Garone, C.
3M ago
Objectives UBTF1 gene encodes for Upstream Binding Transcription Factor, an essential protein for RNA metabolism. A recurrent de novo variant (c.628G>A; p.Glu210Lys) has recently been associated with a childhood-onset neurodegenerative disorder characterized by motor and language regression, ataxia, dystonia, and acquired microcephaly. In this study, we report the clinical, metabolic, molecular genetics and neuroimaging findings and histologic, histochemical, and electron microscopy studies in muscle samples of 2 patients from unrelated families with a neurodevelopmental disorder. Methods D ..read more
Visit website
MTOR Pathway Somatic Pathogenic Variants in Focal Malformations of Cortical Development: Novel Variants, Topographic Mapping, and Clinical Outcomes
Neurology Genetics
by Krochmalnek, E., Accogli, A., St-Onge, J., Addour-Boudrahem, N., Prakash, G., Kim, S.-H., Brunette-Clement, T., Alhajaj, G., Mougharbel, L., Bruneau, E., Myers, K. A., Dubeau, F., Karamchandani, J., Farmer, J.-P., Atkinson, J., Hall, J., Chantal Poulin, C., Rosenblatt, B., Lafond-Lapalme, J., Weil, A., Fallet-Bianco, C., Albrecht, S., Sonenberg, N., Riviere, J.-B., Dudley, R. W., Srour, M.
4M ago
Background and Objectives Somatic and germline pathogenic variants in genes of the mammalian target of rapamycin (mTOR) signaling pathway are a common mechanism underlying a subset of focal malformations of cortical development (FMCDs) referred to as mTORopathies, which include focal cortical dysplasia (FCD) type II, subtypes of polymicrogyria, and hemimegalencephaly. Our objective is to screen resected FMCD specimens with mTORopathy features on histology for causal somatic variants in mTOR pathway genes, describe novel pathogenic variants, and examine the variant distribution in relation to n ..read more
Visit website
FOLR1 Gene Variation With Adult-Onset Cerebral Folate Deficiency and Stable Clinical and MRI Features up to 2 Years
Neurology Genetics
by Manco, C., Cortese, R., Alberti, M., Bianchi, S., Monti, L., De Stefano, N., Battisti, C.
4M ago
Objectives The objective of this case report was to describe the first report of FOLR1 variants associated with adult-onset paucisymptomatic leukoencephalopathy associated with cerebral folate deficiency (CFD). Methods Considering the patient's symptoms, a nonprogressive leukoencephalopathy was suspected. CSF 5-methyltetrahydrofolate levels were low (10 nmol/L, normal range 41–117). With no other identifiable causes, a genetic analysis was conducted, revealing a compound heterozygous FOLR1 variation (c.45G>T and c. 493+2T>C). Results A 47-year-old man with a history of drug and alcohol a ..read more
Visit website
IRF2BPL Causes Mild Intellectual Disability Followed by Late-Onset Ataxia
Neurology Genetics
by Heide, S., Davoine, C.-S., Cunha, P., Scherer-Gagou, C., Keren, B., Stevanin, G., Charles, P., Heron, D., Brice, A., Durr, A.
4M ago
Background and Objectives Neurodevelopmental and neurodegenerative disorders have long been considered as different clinical and molecular entities, and only a few genes are known to be involved in both processes. The IRF2BPL (interferon regulatory factor 2 binding protein like) gene was implicated in a severe pediatric phenotype characterized by developmental and epileptic encephalopathy and early regression. In parallel, inherited IRF2BPL variants have been reported in cohorts of patients with late-onset progressive dystonic and ataxic syndrome with few information about the neurodevelopment ..read more
Visit website

Follow Neurology Genetics on FeedSpot

Continue with Google
Continue with Apple
OR